New Perspectives on the Pathogenesis and Treatment of Alzheimer's Disease

Yvette C. Terrie, BSPharm, RPh
Published Online: Friday, April 27, 2012
Follow Pharmacy_Times:

Pharmacy Times Office of Continuing Professional Education


New Perspectives on the Pathogenesis and Treatment of Alzheimer's Disease

Yvette C. Terrie, BSPharm, RPh

Clinical Pharmacist/Consultant Pharmacist

Haymarket, Virginia


Yvette C. Terrie, BSPharm, RPh, has no relevant affiliations or financial relationships to disclose related to this activity.

Editorial support for this continuing education activity was provided by Elena Beyzarov, PharmD, who has no relevant affiliations or financial relationships to disclose related to this activity.

Judy V. Lum, MPA; Ann C. Lichti, CCMEP; and Donna Fausak of the Pharmacy Times Office of Continuing Professional Education have no relevant affiliations or financial relationships to disclose related to this activity.

Bea Riemschneider, Jennifer Barrio, and David Allikas of Pharmacy Times Editorial have no relevant affiliations or financial relationships to disclose related to this activity.


Educational Objectives

Upon completion of this educational activity, participants should be able to:

  1. Describe the basic etiology and pathophysiology associated with Alzheimer's disease (AD).
  2. Evaluate the epidemiology of AD, as well as its types, stages, and risk factors.
  3. Examine the pharmacist's role in counseling patients and caregivers on AD and related issues.
  4. Discuss the latest research and clinical developments with regard to AD.

Target audience: Pharmacists

Type of activity: Knowledge

Original Activity Title: The Pharmacist's Role in the Management of Alzheimer's Disease

Original Dates of Certification: January 1, 2007, to January 1, 2010

Date of Review: March 15, 2012. This activity has undergone a content review and was updated to reflect the latest research and clinical developments regarding AD.

Current Release date: April 10, 2012

Current Expiration date: April 10, 2014

Estimated time to complete activity: 2 hours

Fee: This lesson is free online

Click here to view this activity.



Related Articles
From optimizing inhaler technique in patients with chronic obstructive pulmonary disease, to catching red flags when dispensing controlled substances to patients with chronic pain, pharmacists can improve patient outcomes in an evolving treatment landscape.
Daniel Abazia, PharmD, BCPS, clinical assistant professor at Ernest Mario School of Pharmacy, talks about how prescription drug monitoring programs assist pharmacists.
In his keynote address at the American Pharmacists Association’s general session, Daniel Kraft, MD, chairman of the medicine and neuroscience tracks for Singularity University, posited that it is time to think outside the box and reimagine health and pharmacy.
The Medical College of Wisconsin is aiming to decide in May whether or not to open a school of pharmacy.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$